Parkinson's Disease, Neuron, vol.39, issue.6, pp.889-909, 2003. ,
DOI : 10.1016/S0896-6273(03)00568-3
??-Synuclein in Lewy bodies, Nature, vol.388, issue.6645, pp.839-879, 1997. ,
DOI : 10.1038/42166
The many faces of ??-synuclein: from structure and toxicity to therapeutic target, Nature Reviews Neuroscience, vol.418, issue.1, pp.38-48, 2013. ,
DOI : 10.1038/418291a
Intravesicular Localization and Exocytosis of ??-Synuclein and its Aggregates, Journal of Neuroscience, vol.25, issue.25, pp.6016-6040, 2005. ,
DOI : 10.1523/JNEUROSCI.0692-05.2005
Non-classical exocytosis of alpha-synuclein is sensitive to folding states and promoted under stress conditions, J Neurochem, vol.113, pp.1263-74, 2010. ,
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease, Neurobiology of Disease, vol.21, issue.2, pp.404-416, 2006. ,
DOI : 10.1016/j.nbd.2005.08.002
Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease, J Neurosci, vol.21, pp.6853-61, 2001. ,
Redundant dopaminergic activity may enable compensatory axonal sprouting in Parkinson disease, Neurology, vol.82, issue.12, pp.1093-1101, 2014. ,
DOI : 10.1212/WNL.0000000000000243
CNS Compensation to Dopamine Neuron Loss in Parkinson???s Disease, Adv Exp Med Biol, vol.90, pp.255-66, 1977. ,
DOI : 10.1007/978-1-4684-2511-6_16
Mutation in the -Synuclein Gene Identified in Families with Parkinson's Disease, Science, vol.276, issue.5321, pp.2045-2052, 1997. ,
DOI : 10.1126/science.276.5321.2045
??-Synuclein Locus Triplication Causes Parkinson's Disease, Science, vol.302, issue.5646, p.841, 2003. ,
DOI : 10.1126/science.1090278
??-synuclein locus duplication as a cause of familial Parkinson's disease, The Lancet, vol.364, issue.9440, pp.1167-1176, 2004. ,
DOI : 10.1016/S0140-6736(04)17103-1
Causal relation between ??-synuclein locus duplication as a cause of familial Parkinson's disease, The Lancet, vol.364, issue.9440, pp.1169-71, 2004. ,
DOI : 10.1016/S0140-6736(04)17104-3
Collaborative Analysis of ??-Synuclein Gene Promoter Variability and Parkinson Disease, JAMA, vol.296, issue.6, pp.661-70, 2006. ,
DOI : 10.1001/jama.296.6.661
URL : https://hal.archives-ouvertes.fr/inserm-00180153
Genome-wide association study reveals genetic risk underlying Parkinson's disease, Nature Genetics, vol.105, issue.12, pp.1308-1320, 2009. ,
DOI : 10.1212/WNL.56.suppl_4.S21
Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance, Journal of Neurochemistry, vol.89, issue.3 Pt 1, pp.59-74, 2016. ,
DOI : 10.1016/j.ajhg.2011.06.008
URL : http://onlinelibrary.wiley.com/doi/10.1111/jnc.13593/pdf
LRRK2 as a modulator of lysosomal calcium homeostasis with downstream effects on autophagy, Autophagy, vol.8, issue.4, pp.692-695, 2012. ,
DOI : 10.4161/auto.19305
The genetics of Parkinson's disease, British Medical Bulletin, vol.114, issue.1, pp.39-52, 2015. ,
DOI : 10.1093/bmb/ldv022
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease, Nature Genetics, vol.21, issue.9, pp.781-786, 2010. ,
DOI : 10.1212/WNL.38.8.1285
A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease, Human Molecular Genetics, vol.22, issue.5, pp.1039-1088, 2013. ,
DOI : 10.1093/hmg/dds492
Genome-wide Pleiotropy between Parkinson disease and autoimmune diseases, JAMA Neurol, vol.74, pp.780-92, 2017. ,
The role of oxidative stress in Parkinson's disease, J Parkinsons Dis, vol.3, pp.461-91, 2013. ,
Understanding Dopaminergic Cell Death Pathways in Parkinson Disease, Neuron, vol.90, issue.4, pp.675-91, 2016. ,
DOI : 10.1016/j.neuron.2016.03.038
URL : https://hal.archives-ouvertes.fr/inserm-01348875
The scientific bases to consider Parkinson's disease an occupational disease in agriculture professionals exposed to pesticides in France, Journal of Epidemiology and Community Health, vol.10, issue.4, pp.319-340, 2016. ,
DOI : 10.1371/journal.pgen.1004788
Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases, Frontiers in Cellular Neuroscience, vol.115, p.124, 2015. ,
DOI : 10.1111/j.1471-4159.2010.07002.x
URL : http://journal.frontiersin.org/article/10.3389/fncel.2015.00124/pdf
Neurotoxin-based models of Parkinson's disease, Neuroscience, vol.211, pp.51-76, 2012. ,
DOI : 10.1016/j.neuroscience.2011.10.057
Oxidation reactions in Parkinson's disease, Neurology, vol.40, 1990. ,
DOI : 10.1002/ana.24011
Mitochondrial dysfunction in Parkinson's disease, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1802, issue.1, pp.29-44, 2010. ,
DOI : 10.1016/j.bbadis.2009.08.013
Oxidative DNA Damage in the Parkinsonian Brain: An Apparent Selective Increase in 8-Hydroxyguanine Levels in Substantia Nigra, Journal of Neurochemistry, vol.69, issue.3, pp.1196-203, 1997. ,
DOI : 10.1046/j.1471-4159.1997.69031196.x
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease, Journal of Neurochemistry, vol.46, issue.2, pp.381-390, 1989. ,
DOI : 10.1016/0028-3908(87)90187-0
Parkinson's Disease Is Associated with Oxidative Damage to Cytoplasmic DNA and RNA in Substantia Nigra Neurons, The American Journal of Pathology, vol.154, issue.5, pp.1423-1432, 1999. ,
DOI : 10.1016/S0002-9440(10)65396-5
Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease, Neuroscience Letters, vol.142, issue.2, pp.128-158, 1992. ,
DOI : 10.1016/0304-3940(92)90355-B
Glutathione peroxidase, glial cells and Parkinson's disease, Neuroscience, vol.52, issue.1, pp.1-6, 1993. ,
DOI : 10.1016/0306-4522(93)90175-F
Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude, Acta Neuropathol, vol.101, pp.249-55, 2001. ,
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain, Neuroscience, vol.39, issue.1, pp.151-70, 1990. ,
DOI : 10.1016/0306-4522(90)90229-W
Mitochondrial Complex I Deficiency in Parkinson's Disease, Journal of Neurochemistry, vol.49, issue.3, pp.823-830, 1990. ,
DOI : 10.1016/S0140-6736(88)91894-6
Reductase (Complex I) Deficiency in Parkinson's Disease, Journal of Neurochemistry, vol.54, issue.6, pp.2142-2147, 1990. ,
DOI : 10.1016/0076-6879(67)10048-7
Deficiencies in Complex I subunits of the respiratory chain in Parkinson's disease, Biochemical and Biophysical Research Communications, vol.163, issue.3, pp.1450-1455, 1989. ,
DOI : 10.1016/0006-291X(89)91141-8
Biochemical aspects of phagocytosis in poly-morphonuclear leucocytes. NADH and NADPH oxidation by the granules of resting and phagocytizing cells, Experientia, vol.112, issue.1, pp.21-24, 1964. ,
DOI : 10.1139/o63-051
HOW NEUTROPHILS KILL MICROBES, Annual Review of Immunology, vol.23, issue.1, pp.197-223, 2005. ,
DOI : 10.1146/annurev.immunol.23.021704.115653
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2092448/pdf
A mammalian H+ channel generated through alternative splicing of the NADPH oxidase homolog NOH-1, Science, vol.287, pp.138-180, 2000. ,
Cell transformation by the superoxide-generating oxidase Mox1, Nature, vol.273, issue.6748, pp.79-82, 1999. ,
DOI : 10.1074/jbc.273.4.2015
Homologs of gp91 phox : cloning and tissue expression of Nox3, Nox4, and Nox5, Gene, vol.269, issue.1-2, pp.131-171, 2001. ,
DOI : 10.1016/S0378-1119(01)00449-8
Identification of Renox, an NAD(P)H oxidase in kidney, Proceedings of the National Academy of Sciences, vol.145, issue.8, pp.8010-8014, 2000. ,
DOI : 10.1046/j.1523-1755.1998.00212.x
A Novel Superoxide-producing NAD(P)H Oxidase in Kidney, Journal of Biological Chemistry, vol.201, issue.2, pp.1417-1440, 2001. ,
DOI : 10.1073/pnas.130135897
URL : http://www.jbc.org/content/276/2/1417.full.pdf
-activated NADPH Oxidase in Testis, Spleen, and Lymph Nodes, Journal of Biological Chemistry, vol.10, issue.40, pp.37594-601, 2001. ,
DOI : 10.1084/jem.193.4.417
Cloning of Two Human Thyroid cDNAs Encoding New Members of the NADPH Oxidase Family, Journal of Biological Chemistry, vol.278, issue.30, pp.23227-23260, 2000. ,
DOI : 10.1006/abio.1997.2055
Conserved Cysteine Residues Provide a Protein-Protein Interaction Surface in Dual Oxidase (DUOX) Proteins, Journal of Biological Chemistry, vol.101, issue.10, pp.7147-57, 2013. ,
DOI : 10.1172/JCI2649
URL : http://www.jbc.org/content/288/10/7147.full.pdf
and Human Dual Oxidase 1 (DUOX1) ???Peroxidase??? Domains, Journal of Biological Chemistry, vol.11, issue.28, pp.18634-18677, 2009. ,
DOI : 10.1074/jbc.274.15.10533
URL : http://www.jbc.org/content/284/28/18634.full.pdf
Structural stability and heme binding potential of the truncated human dual oxidase 2 (DUOX2) peroxidase domain, Archives of Biochemistry and Biophysics, vol.512, issue.2, pp.197-203, 2011. ,
DOI : 10.1016/j.abb.2011.05.021
Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement, Antioxidants & Redox Signaling, vol.23, issue.5, pp.406-433, 2015. ,
DOI : 10.1089/ars.2013.5814
Molecular evolution of the reactive oxygen-generating NADPH oxidase (Nox/Duox) family of enzymes, BMC Evolutionary Biology, vol.7, issue.1, p.109, 2007. ,
DOI : 10.1186/1471-2148-7-109
Regulation of Nox and Duox enzymatic activity and expression, Free Radical Biology and Medicine, vol.43, issue.3, pp.319-350, 2007. ,
DOI : 10.1016/j.freeradbiomed.2007.03.028
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1989153/pdf
Gp91phox is the heme binding subunit of the superoxide-generating NADPH oxidase, Proceedings of the National Academy of Sciences, vol.321, issue.5, pp.7993-8001, 1998. ,
DOI : 10.1042/bj3210583
Regulation of the Neutrophil Respiratory Burst Oxidase, Journal of Biological Chemistry, vol.269, issue.27, pp.16663-16671, 1998. ,
DOI : 10.1021/bi00249a031
Stimulus-dependent Regulation of the Phagocyte NADPH Oxidase by a VAV1, Rac1, and PAK1 Signaling Axis, Journal of Biological Chemistry, vol.96, issue.12, pp.7983-93, 2008. ,
DOI : 10.1172/JCI118187
Impaired NADPH oxidase activity in Rac2-deficient murine neutrophils does not result from defective translocation of p47phox and p67phox and can be rescued by exogenous arachidonic acid, Journal of Leukocyte Biology, vol.79, issue.1, pp.223-257, 2006. ,
DOI : 10.1189/jlb.0705371
Generation but Not Degranulation or Adherence in Differentiated HL60 Cells, Journal of Biological Chemistry, vol.264, issue.42, pp.27292-27301, 1998. ,
DOI : 10.1073/pnas.92.17.7931
URL : http://www.jbc.org/content/273/42/27292.full.pdf
Protein Kinase C?? Is Required for p47phox Phosphorylation and Translocation in Activated Human Monocytes, The Journal of Immunology, vol.173, issue.9, pp.5730-5738, 2004. ,
DOI : 10.4049/jimmunol.173.9.5730
Involvement of protein kinase C?? in the activation of NADPH oxidase and the phagocytosis of neutrophils, Free Radical Research, vol.349, issue.4, pp.359-67, 2006. ,
DOI : 10.1042/bj3490369
Modulation of p47PHOX activity by site-specific phosphorylation: Akt-dependent activation of the NADPH oxidase, Proceedings of the National Academy of Sciences, vol.274, issue.29, pp.5130-5135, 2003. ,
DOI : 10.1074/jbc.274.29.20704
Akt Phosphorylates p47phox and Mediates Respiratory Burst Activity in Human Neutrophils, The Journal of Immunology, vol.170, issue.10, pp.5302-5310, 2003. ,
DOI : 10.4049/jimmunol.170.10.5302
URL : http://www.jimmunol.org/content/jimmunol/170/10/5302.full.pdf
A specific p47phox -serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites, Journal of Clinical Investigation, vol.116, issue.7, pp.2033-2076, 2006. ,
DOI : 10.1172/JCI27544
URL : http://www.jci.org/articles/view/27544/files/pdf
p21-activated kinase (Pak) regulates NADPH oxidase activation in human neutrophils, Blood, vol.106, issue.12, pp.3962-3971, 2005. ,
DOI : 10.1182/blood-2005-03-0859
URL : http://www.bloodjournal.org/content/bloodjournal/106/12/3962.full.pdf
TNF-?? Induces Phosphorylation of p47phox in Human Neutrophils: Partial Phosphorylation of p47phox Is a Common Event of Priming of Human Neutrophils by TNF-?? and Granulocyte-Macrophage Colony-Stimulating Factor, The Journal of Immunology, vol.171, issue.8, pp.4392-4400, 2003. ,
DOI : 10.4049/jimmunol.171.8.4392
Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases, Cellular Signalling, vol.18, issue.1, pp.69-82, 2006. ,
DOI : 10.1016/j.cellsig.2005.03.023
NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation, Biochemical Journal, vol.406, issue.1, pp.105-119, 2007. ,
DOI : 10.1042/BJ20061903
URL : https://hal.archives-ouvertes.fr/hal-00400481
Nox4 NADPH oxidase-derived reactive oxygen species, via endogenous carbon monoxide, promote survival of brain endothelial cells during TNF-??-induced apoptosis, AJP: Cell Physiology, vol.300, issue.2, pp.256-65, 2011. ,
DOI : 10.1152/ajpcell.00272.2010
Insulin-like growth factor-I induces reactive oxygen species production and cell migration through Nox4 and Rac1 in vascular smooth muscle cells, Cardiovascular Research, vol.80, issue.2, pp.299-308, 2008. ,
DOI : 10.1093/cvr/cvn173
URL : https://academic.oup.com/cardiovascres/article-pdf/80/2/299/993895/cvn173.pdf
NADPH oxidase 4 mediates TGF-??-induced smooth muscle ??-actin via p38MAPK and serum response factor, Free Radical Biology and Medicine, vol.50, issue.2, pp.354-62, 2011. ,
DOI : 10.1016/j.freeradbiomed.2010.11.007
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032946/pdf
Novel Mechanism of Activation of NADPH Oxidase 5, Journal of Biological Chemistry, vol.20, issue.9, pp.6494-507, 2007. ,
DOI : 10.1161/01.ATV.20.8.1903
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology, Physiological Reviews, vol.87, issue.1, pp.245-313, 2007. ,
DOI : 10.1152/physrev.00044.2005
Expression of Nox genes in rat organs, mouse oocytes, and sea urchin eggs, DNA Sequence, vol.16, issue.2, pp.83-91, 2005. ,
DOI : 10.1080/10425170500069734
Activation of microglia with zymosan promotes excitatory amino acid release via volume-regulated anion channels: the role of NADPH oxidases, Journal of Neurochemistry, vol.18, issue.6, pp.2449-62, 2008. ,
DOI : 10.1161/01.STR.25.1.165
Measurement and Characterization of Superoxide Generation in Microglial Cells: Evidence for an NADPH Oxidase-Dependent Pathway, Archives of Biochemistry and Biophysics, vol.353, issue.2, pp.312-333, 1998. ,
DOI : 10.1006/abbi.1998.0658
, a Component of the Phagocyte NADPH Oxidase, in Microglial Cells during Central Nervous System Inflammation, Journal of Cerebral Blood Flow & Metabolism, vol.6, issue.1, pp.374-84, 2001. ,
DOI : 10.1016/0960-5428(96)00017-4
Neurotoxic Activation of Microglia Is Promoted by a Nox1-Dependent NADPH Oxidase, Journal of Neuroscience, vol.28, issue.46, pp.12039-51, 2008. ,
DOI : 10.1523/JNEUROSCI.3568-08.2008
URL : https://hal.archives-ouvertes.fr/pasteur-00428978
NOX4 Expression in Human Microglia Leads to Constitutive Generation of Reactive Oxygen Species and to Constitutive IL-6 Expression, Journal of Innate Immunity, vol.1, issue.6, pp.570-81, 2009. ,
DOI : 10.1159/000235563
Microglial neurotransmitter receptors trigger superoxide production in microglia; consequences for microglial-neuronal interactions, Journal of Neurochemistry, vol.3, issue.2, pp.287-301, 2012. ,
DOI : 10.1038/nprot.2007.473
The phagocyte NADPH oxidase depends on cholesterol-enriched membrane microdomains for assembly, The EMBO Journal, vol.23, issue.4, pp.739-787, 2004. ,
DOI : 10.1038/sj.emboj.7600066
NADPH Oxidase Is Internalized by Clathrin-coated Pits and Localizes to a Rab27A/B GTPase-regulated Secretory Compartment in Activated Macrophages, Journal of Biological Chemistry, vol.1746, issue.7, pp.4835-52, 2012. ,
DOI : 10.1038/nrm1572
NOX1/NADPH oxidase negatively regulates nerve growth factor-induced neurite outgrowth, Free Radical Biology and Medicine, vol.40, issue.10, pp.1785-95, 2006. ,
DOI : 10.1016/j.freeradbiomed.2006.01.009
NADPH oxidase contributes directly to oxidative stress and apoptosis in nerve growth factor-deprived sympathetic neurons, J Neurosci, vol.20, p.53, 2000. ,
Immunohistochemical study of p47Phox and gp91Phox distributions in rat brain, Brain Research, vol.1040, issue.1-2, pp.178-86, 2005. ,
DOI : 10.1016/j.brainres.2005.01.066
Neuronal expression of the NADPH oxidase NOX4, and its regulation in mouse experimental brain ischemia, Neuroscience, vol.132, issue.2, pp.233-241, 2005. ,
DOI : 10.1016/j.neuroscience.2004.12.038
Mitochondrial-localized NADPH oxidase 4 is a source of superoxide in angiotensin II-stimulated neurons, AJP: Heart and Circulatory Physiology, vol.305, issue.1, pp.19-28, 2013. ,
DOI : 10.1152/ajpheart.00974.2012
NADPH Oxidase 1-Mediated Oxidative Stress Leads to Dopamine Neuron Death in Parkinson's Disease, Antioxidants & Redox Signaling, vol.16, issue.10, pp.1033-1078, 2012. ,
DOI : 10.1089/ars.2011.3960
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315177/pdf
Loss of angiotensin II receptor expression in dopamine neurons in Parkinson???s disease correlates with pathological progression and is accompanied by increases in Nox4- and 8-OH guanosine-related nucleic acid oxidation and caspase-3 activation, Acta Neuropathologica Communications, vol.4, issue.8, p.9, 2015. ,
DOI : 10.3389/fendo.2013.00158
Expression and Modulation of an NADPH Oxidase in Mammalian Astrocytes, Journal of Neuroscience, vol.25, issue.40, pp.9176-84, 2005. ,
DOI : 10.1523/JNEUROSCI.1632-05.2005
Location of nitroblue tetrazolium-reducing activity in human colonic mucosa obtained by biopsy, Digestive Diseases and Sciences, vol.134, issue.3, pp.546-50, 1993. ,
DOI : 10.1007/BF01316513
NADPH oxidases: an overview from structure to innate immunity-associated pathologies, Cellular and Molecular Immunology, vol.296, issue.1, pp.5-23, 2015. ,
DOI : 10.1002/hep.24599
URL : http://www.nature.com/cmi/journal/v12/n1/pdf/cmi201489a.pdf
NADPH oxidase is required for NMDA receptor-dependent activation of ERK in hippocampal area CA1, Journal of Neurochemistry, vol.275, issue.2 ,
DOI : 10.1074/jbc.M910425199
Synaptic Plasticity Deficits and Mild Memory Impairments in Mouse Models of Chronic Granulomatous Disease, Molecular and Cellular Biology, vol.26, issue.15, pp.5908-5928, 2006. ,
DOI : 10.1128/MCB.00269-06
A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation, Journal of Neuroimmunology, vol.90, issue.2, pp.113-134, 1998. ,
DOI : 10.1016/S0165-5728(98)00145-3
Neuroinflammation in Parkinson's disease, Parkinsonism & Related Disorders, vol.18, pp.210-212, 2012. ,
DOI : 10.1016/S1353-8020(11)70065-7
NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease, Proceedings of the National Academy of Sciences, vol.290, issue.5493, pp.6145-50, 2003. ,
DOI : 10.1126/science.290.5493.985
Plasticity of Subventricular Zone Neuroprogenitors in MPTP (1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine) Mouse Model of Parkinson's Disease Involves Cross Talk between Inflammatory and Wnt/??-Catenin Signaling Pathways: Functional Consequences for Neuroprotection and Repair, Journal of Neuroscience, vol.32, issue.6, pp.2062-85, 2012. ,
DOI : 10.1523/JNEUROSCI.5259-11.2012
Blockade of microglial activation is neuroprotective in the 1-methyl-4, p.6, 2003. ,
Ethyl Pyruvate Rescues Nigrostriatal Dopaminergic Neurons by Regulating Glial Activation in a Mouse Model of Parkinson's Disease, The Journal of Immunology, vol.187, issue.2, pp.960-969, 2011. ,
DOI : 10.4049/jimmunol.1100009
Minimally toxic dose of Lipopolysaccharide and alpha-Synuclein Oligomer elicit synergistic Dopaminergic Neurodegeneration: role and mechanism of Microglial NOX2 activation, Mol Neurobiol, 2016. ,
Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration, Neurobiology of Disease, vol.25, issue.2, pp.392-400, 2007. ,
DOI : 10.1016/j.nbd.2006.10.008
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001246/pdf
Microglial Cells Are Involved in the Susceptibility of NADPH Oxidase Knockout Mice to 6-Hydroxy-Dopamine-Induced Neurodegeneration, PLoS ONE, vol.6, issue.9, p.75532, 2013. ,
DOI : 10.1371/journal.pone.0075532.g006
Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons, Journal of Neurochemistry, vol.186, issue.2, pp.145-56, 2007. ,
DOI : 10.1073/pnas.0937239100
Ultrafine carbon particles promote rotenone-induced dopamine neuronal loss through activating microglial NADPH oxidase, Toxicology and Applied Pharmacology, vol.322, pp.51-60, 2017. ,
DOI : 10.1016/j.taap.2017.03.005
Traumatic brain injury in aged animals increases lesion size and chronically alters microglial/macrophage classical and alternative activation states, Neurobiology of Aging, vol.34, issue.5, pp.1397-411, 2013. ,
DOI : 10.1016/j.neurobiolaging.2012.11.013
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572914/pdf
Delayed mGluR5 activation limits neuroinflammation and neurodegeneration after traumatic brain injury, Journal of Neuroinflammation, vol.12, issue.1, p.43, 2012. ,
DOI : 10.1089/neu.1995.12.169
URL : https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/1742-2094-9-43?site=jneuroinflammation.biomedcentral.com
NOX2 drives M1-like microglial/macrophage activation and neurodegeneration following experimental traumatic brain injury, Brain, Behavior, and Immunity, vol.58, pp.291-309, 2016. ,
DOI : 10.1016/j.bbi.2016.07.158
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067217/pdf
FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells, J Neurosci, vol.19, pp.3440-3447, 1999. ,
Tumor necrosis factor-?? (TNF-??) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients, Neuroscience Letters, vol.165, issue.1-2, pp.208-218, 1994. ,
DOI : 10.1016/0304-3940(94)90746-3
Interleukin (IL)-1??, IL-2, IL-4, IL-6 and transforming growth factor-?? levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease, Neuroscience Letters, vol.211, issue.1, pp.13-19, 1996. ,
DOI : 10.1016/0304-3940(96)12706-3
Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway, Proceedings of the National Academy of Sciences, vol.20, issue.14, pp.8514-8523, 2003. ,
DOI : 10.1038/399a007
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration, Glia, vol.19, issue.5, pp.453-62, 2007. ,
DOI : 10.1515/REVNEURO.2002.13.3.221
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871685/pdf
Functional diversity of microglia -how heterogeneous are they to begin with? Front Cell Neurosci, p.65, 2013. ,
Glutathione--a review on its role and significance in Parkinson's disease, The FASEB Journal, vol.23, issue.10, pp.3263-72, 2009. ,
DOI : 10.1096/fj.08-125443
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene, Science, vol.282, issue.5396, pp.2085-2093, 1998. ,
DOI : 10.1126/science.282.5396.2085
Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product ,
Interactive role of the toll-like receptor 4 and reactive oxygen species in LPS-induced microglia activation, Glia, vol.19, issue.1, pp.78-84, 2005. ,
DOI : 10.4049/jimmunol.166.1.574
MAC1 mediates LPS-induced production of superoxide by microglia: The role of pattern recognition receptors in dopaminergic neurotoxicity, Glia, vol.170, issue.13, pp.1362-73, 2007. ,
DOI : 10.1084/jem.170.4.1231
NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration, Glia, vol.46, issue.Suppl 1, pp.855-68, 2013. ,
DOI : 10.1016/j.freeradbiomed.2008.10.031
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631289/pdf
NADPH Oxidase Mediates Lipopolysaccharide-induced Neurotoxicity and Proinflammatory Gene Expression in Activated Microglia, Journal of Biological Chemistry, vol.20, issue.2, pp.1415-1436, 2004. ,
DOI : 10.1074/jbc.M111883200
URL : http://www.jbc.org/content/279/2/1415.full.pdf
Substance P enhances microglial density in the substantia nigra through neurokinin-1 receptor/NADPH oxidase-mediated chemotaxis in mice, Clinical Science, vol.129, issue.8, pp.757-67, 2015. ,
DOI : 10.1042/CS20150008
Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease, The FASEB Journal, vol.17, pp.1954-1960, 2003. ,
DOI : 10.1096/fj.03-0109fje
Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease, The FASEB Journal, vol.17, pp.1957-1966, 2003. ,
DOI : 10.1096/fj.03-0203fje
The Role of Microglia in Paraquat-Induced Dopaminergic Neurotoxicity, Antioxidants & Redox Signaling, vol.7, issue.5-6, pp.654-61, 2005. ,
DOI : 10.1089/ars.2005.7.654
Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons, J Neurosci, vol.23, pp.6181-6188, 2003. ,
Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase, The FASEB Journal, vol.18, pp.589-91, 2004. ,
DOI : 10.1096/fj.03-0983fje
NADPH Oxidase and the Degeneration of Dopaminergic Neurons in Parkinsonian Mice, Oxidative Medicine and Cellular Longevity, vol.22, issue.5, p.157857, 2013. ,
DOI : 10.1046/j.1471-4159.2002.00928.x
Microglial Activation and Antioxidant Responses Induced by the Parkinson???s Disease Protein ??-Synuclein, Journal of Neuroimmune Pharmacology, vol.19, issue.6, pp.94-117, 2013. ,
DOI : 10.1096/fj.04-2751com
Triggering of Inflammasome by Aggregated ?????Synuclein, an Inflammatory Response in Synucleinopathies, PLoS ONE, vol.14, issue.1, p.55375, 2013. ,
DOI : 10.1371/journal.pone.0055375.s004
Neuronreleased oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia, Nat Commun, vol.2013, p.1562 ,
Toll-like receptor 4 is required for ??-synuclein dependent activation of microglia and astroglia, Glia, vol.19, issue.Suppl 1, pp.349-60, 2013. ,
DOI : 10.1096/fj.04-2751com
Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein, Glia, vol.4, issue.11, pp.1178-88, 2007. ,
DOI : 10.1515/REVNEURO.2005.16.2.123
P2X7 receptor is critical in ??-synuclein???mediated microglial NADPH oxidase activation, Neurobiology of Aging, vol.36, issue.7, pp.2304-2322, 2015. ,
DOI : 10.1016/j.neurobiolaging.2015.03.015
Elevated neuronal ??-synuclein promotes microglia activation after spinal cord ischemic/reperfused injury, NeuroReport, vol.26, issue.11, pp.656-61, 2015. ,
DOI : 10.1097/WNR.0000000000000406
Identification of a specific ??-synuclein peptide (??-Syn 29-40) capable of eliciting microglial superoxide production to damage dopaminergic neurons, Journal of Neuroinflammation, vol.17, issue.7, p.158, 2016. ,
DOI : 10.1038/sj.leu.2402945
MHCII Is Required for ??-Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation, and Dopaminergic Neurodegeneration, Journal of Neuroscience, vol.33, issue.23, pp.9592-600, 2013. ,
DOI : 10.1523/JNEUROSCI.5610-12.2013
-dependent Lyn phosphorylation, Proceedings of the National Academy of Sciences, vol.71, issue.4, pp.1926-1961, 2015. ,
DOI : 10.1016/j.freeradbiomed.2006.08.002
Park7 interacts with p47phox to direct NADPH oxidase-dependent ROS production and protect against sepsis, Cell Research, vol.2012, issue.6, pp.691-706, 2015. ,
DOI : 10.1001/jama.2011.909
URL : http://www.nature.com/cr/journal/v25/n6/pdf/cr201563a.pdf
DJ-1/PARK7 Impairs Bacterial Clearance in Sepsis, American Journal of Respiratory and Critical Care Medicine, vol.189, issue.7, pp.889-905, 2017. ,
DOI : 10.1001/jama.2016.0287
Deficient Production of Reactive Oxygen Species Leads to Severe Chronic DSS-Induced Colitis in Ncf1/p47phox-Mutant Mice, PLoS ONE, vol.209, issue.5, p.97532, 2014. ,
DOI : 10.1371/journal.pone.0097532.g008
Inflammation is genetically implicated in Parkinson???s disease, Neuroscience, vol.302, pp.89-102, 2015. ,
DOI : 10.1016/j.neuroscience.2014.10.028
The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson???s disease, Neuroscience, vol.302, pp.74-88, 2015. ,
DOI : 10.1016/j.neuroscience.2014.09.049
Synaptic localization of a functional NADPH oxidase in the mouse hippocampus, Molecular and Cellular Neuroscience, vol.29, issue.1, pp.97-106, 2005. ,
DOI : 10.1016/j.mcn.2005.01.007
Association of gp91phox homolog Nox1 with anchorage-independent growth and MAP kinase-activation of transformed human keratinocytes, Oncogene, vol.22, issue.38, pp.6045-53, 2003. ,
DOI : 10.1016/S0006-291X(02)02059-4
Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors, Cancer Biology & Therapy, vol.4, issue.12, pp.1367-73, 2005. ,
DOI : 10.4161/cbt.4.12.2233
URL : http://www.tandfonline.com/doi/pdf/10.4161/cbt.4.12.2233?needAccess=true
The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells, Genes to Cells, vol.295, issue.12, pp.1139-51, 2005. ,
DOI : 10.1074/jbc.M414548200
The Role of NADPH Oxidase 1???Derived Reactive Oxygen Species in Paraquat-Mediated Dopaminergic Cell Death, Antioxidants & Redox Signaling, vol.11, issue.9, pp.2105-2123, 2009. ,
DOI : 10.1089/ars.2009.2459
NADPH Oxidase 1 Mediates ??-Synucleinopathy in Parkinson's Disease, Journal of Neuroscience, vol.32, issue.42, pp.14465-77, 2012. ,
DOI : 10.1523/JNEUROSCI.2246-12.2012
URL : http://www.jneurosci.org/content/jneuro/32/42/14465.full.pdf
Therapeutic Effects of Fucoidan in 6-Hydroxydopamine-Lesioned Rat Model of Parkinson's disease: Role of NADPH oxidase-1, CNS Neuroscience & Therapeutics, vol.35, issue.12, pp.1036-1080, 2014. ,
DOI : 10.1042/BST0351127
Stages in the development of Parkinson???s disease-related pathology, Cell and Tissue Research, vol.16, issue.Suppl 2, pp.121-155, 2004. ,
DOI : 10.1007/s00441-004-0956-9
Nox4-Generated Superoxide Drives Angiotensin II-Induced Neural Stem Cell Proliferation, Developmental Neuroscience, vol.35, issue.4, pp.293-305, 2013. ,
DOI : 10.1159/000350502
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889712/pdf
Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade, Journal of Neuroinflammation, vol.8, issue.1, p.129, 2011. ,
DOI : 10.1073/pnas.0502552102
Aging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration, Neurobiology of Aging, vol.33, issue.1, pp.204-201, 2012. ,
DOI : 10.1016/j.neurobiolaging.2010.08.006
Link between Mitochondria and NADPH Oxidase 1 Isozyme for the Sustained Production of Reactive Oxygen Species and Cell Death, Journal of Biological Chemistry, vol.24, issue.47, pp.36228-36263, 2006. ,
DOI : 10.1101/gad.1223004
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson???s Disease, Neuron, vol.85, issue.2, pp.257-73, 2015. ,
DOI : 10.1016/j.neuron.2014.12.007
PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-Induced Cell Death, Molecular Cell, vol.33, issue.5, pp.627-665, 2009. ,
DOI : 10.1016/j.molcel.2009.02.013
URL : https://doi.org/10.1016/j.molcel.2009.02.013
Cross talk between mitochondria and NADPH oxidases, Free Radical Biology and Medicine, vol.51, issue.7, pp.1289-301, 2011. ,
DOI : 10.1016/j.freeradbiomed.2011.06.033
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163726/pdf
ROS-induced ROS release in vascular biology: redox-redox signaling, AJP: Heart and Circulatory Physiology, vol.301, issue.3, pp.647-53, 2011. ,
DOI : 10.1152/ajpheart.01271.2010
URL : http://ajpheart.physiology.org/content/ajpheart/301/3/H647.full.pdf
A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine???acetylcholine synaptic balance, The Lancet Neurology, vol.5, issue.11, pp.974-983, 2006. ,
DOI : 10.1016/S1474-4422(06)70600-7
Modulation of the glutamatergic transmission by Dopamine: a focus on Parkinson, Huntington and Addiction diseases, Frontiers in Cellular Neuroscience, vol.120, p.25, 2015. ,
DOI : 10.1016/s0306-4522(03)00326-9
Paradoxical actions of hydrogen peroxide on long-term potentiation in transgenic superoxide dismutase-1 mice, J Neurosci, vol.23, pp.10359-67, 2003. ,
Glutamate NMDA receptor dysregulation in Parkinson???s disease with dyskinesias, Brain, vol.134, issue.4, pp.979-86, 2011. ,
DOI : 10.1093/brain/awr028
URL : https://academic.oup.com/brain/article-pdf/134/4/979/17863143/awr028.pdf
Interleukin-6 Mediates the Increase in NADPH-Oxidase in the Ketamine Model of Schizophrenia, Journal of Neuroscience, vol.28, issue.51, pp.13957-66, 2008. ,
DOI : 10.1523/JNEUROSCI.4457-08.2008
Initial evidence linking synaptic superoxide production with poor short-term memory in aged mice, Brain Research, vol.1368, pp.65-70, 2011. ,
DOI : 10.1016/j.brainres.2010.11.009
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018762/pdf
NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation, Nature Neuroscience, vol.169, issue.7, pp.857-63, 2009. ,
DOI : 10.1097/00004647-200002000-00018
The NADPH Oxidase NOX2 Controls Glutamate Release: A Novel Mechanism Involved in Psychosis-Like Ketamine Responses, Journal of Neuroscience, vol.30, issue.34, pp.11317-11342, 2010. ,
DOI : 10.1523/JNEUROSCI.1491-10.2010
Requirement for Superoxide in Excitotoxic Cell Death, Neuron, vol.16, issue.2, pp.345-55, 1996. ,
DOI : 10.1016/S0896-6273(00)80052-5
URL : https://doi.org/10.1016/s0896-6273(00)80052-5
Phosphoinositide 3-kinase couples NMDA receptors to superoxide release in excitotoxic neuronal death, Cell Death and Disease, vol.758, issue.4, p.580, 2013. ,
DOI : 10.1007/978-1-61779-170-3_11
URL : http://www.nature.com/cddis/journal/v4/n5/pdf/cddis2013164a.pdf
Involvement of the immune system, endocytosis and EIF2 signaling in both genetically determined and sporadic forms of Parkinson's disease, Neurobiology of Disease, vol.63, pp.165-170, 2014. ,
DOI : 10.1016/j.nbd.2013.11.007
Expression analysis of dopaminergic neurons in Parkinson???s disease and aging links transcriptional dysregulation of energy metabolism to cell death, Acta Neuropathologica, vol.137, issue.Suppl 2, pp.75-86, 2011. ,
DOI : 10.1002/ajmg.b.30195
Rotenone induces apoptosis in human lung cancer cells by regulating autophagic flux, IUBMB Life, vol.175, issue.5, pp.388-93, 2016. ,
DOI : 10.1083/jcb.200512100
URL : http://onlinelibrary.wiley.com/doi/10.1002/iub.1493/pdf
Rapamycin protects against rotenone-induced apoptosis through autophagy induction, Neuroscience, vol.164, issue.2, pp.541-51, 2009. ,
DOI : 10.1016/j.neuroscience.2009.08.014
Autophagy protects the rotenone-induced cell death in ??-synuclein overexpressing SH-SY5Y cells, Neuroscience Letters, vol.472, issue.1, pp.47-52, 2010. ,
DOI : 10.1016/j.neulet.2010.01.053
Src-dependent impairment of autophagy by oxidative stress in a mouse model of Duchenne muscular dystrophy, Nature Communications, vol.52, p.4425, 2014. ,
DOI : 10.1016/j.febslet.2013.12.011
NADPH oxidase promotes Parkinsonian phenotypes by impairing autophagic flux in an mTORC1-independent fashion in a cellular model of Parkinson???s disease, Scientific Reports, vol.8, issue.1, p.22866, 2016. ,
DOI : 10.1371/journal.pone.0068060
NOX4 mediates cytoprotective autophagy induced by the EGFR inhibitor erlotinib in head and neck cancer cells, Toxicology and Applied Pharmacology, vol.272, issue.3, pp.736-781, 2013. ,
DOI : 10.1016/j.taap.2013.07.013
Activation of NADPH Oxidase 4 in the Endoplasmic Reticulum Promotes Cardiomyocyte Autophagy and Survival During Energy Stress Through the Protein Kinase RNA-Activated-Like Endoplasmic Reticulum Kinase/Eukaryotic Initiation Factor 2??/Activating Transcription Factor 4 Pathway, Circulation Research, vol.113, issue.11, pp.1253-64, 2013. ,
DOI : 10.1161/CIRCRESAHA.113.301787
Targeting Mitochondria for Neuroprotection in Parkinson's Disease, Antioxidants & Redox Signaling, vol.16, issue.9, pp.965-73, 2012. ,
DOI : 10.1089/ars.2011.4419
Classical Inhibitors of NOX NAD(P)H Oxidases Are Not Specific, Current Drug Metabolism, vol.9, issue.8, pp.686-96, 2008. ,
DOI : 10.2174/138920008786049285
Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney ,
First in Class, Potent, and Orally Bioavailable NADPH Oxidase Isoform 4 (Nox4) Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis, Journal of Medicinal Chemistry, vol.53, issue.21, pp.7715-7745, 2010. ,
DOI : 10.1021/jm100773e
Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent, Hepatology, vol.115, issue.6, pp.2316-2343, 2012. ,
DOI : 10.1016/j.freeradbiomed.2012.05.007
Therapeutic potential of NADPH oxidase 1/4 inhibitors, British Journal of Pharmacology, vol.131, issue.Database Issue, pp.1647-69, 2017. ,
DOI : 10.1161/CIRCULATIONAHA.114.011079
URL : http://onlinelibrary.wiley.com/doi/10.1111/bph.13532/pdf
NOX2 As a Target for Drug Development: Indications, Possible Complications, and Progress, Antioxidants & Redox Signaling, vol.23, issue.5, pp.375-405, 2015. ,
DOI : 10.1089/ars.2014.5862
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545678/pdf
Reactive oxygen species in vascular biology: implications in hypertension, Histochemistry and Cell Biology, vol.108, issue.4, pp.339-52, 2004. ,
DOI : 10.1007/s00418-004-0696-7
Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension?, AJP: Regulatory, Integrative and Comparative Physiology, vol.289, issue.4, pp.913-948, 2005. ,
DOI : 10.1152/ajpregu.00250.2005
Apocyanin, NADPH oxidase inhibitor prevents lipopolysaccharide induced ??-synuclein aggregation and ameliorates motor function deficits in rats: Possible role of biochemical and inflammatory alterations, Behavioural Brain Research, vol.296, pp.177-90, 2016. ,
DOI : 10.1016/j.bbr.2015.09.012
Subpicomolar diphenyleneiodonium inhibits microglial NADPH oxidase with high specificity and shows great potential as a therapeutic agent for neurodegenerative diseases, Glia, vol.281, issue.Pt 1, pp.62-2034, 2014. ,
DOI : 10.1074/jbc.M607191200